Atrovent Aerosol, Metered
Product Images NDC 0597-0087

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atrovent (NDC 0597-0087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Atrovent 01)

Chemical structure of ipratropium bromide, the active ingredient in Atrovent HFA. The diagram includes the molecular framework with labeled bromide and water components (Br: H2O).*

FDA Label Image

Figure 1 (Atrovent 02)

Two line graphs showing FEV1 (liters) over 8 hours after drug administration on Day 1 and Day 85. The graphs compare placebo with ipratropium bromide HFA doses of 42 mcg and 84 mcg, and ipratropium bromide CFC 42 mcg, illustrating their effects on lung function over time.*

FDA Label Image

Figure 1 (Atrovent 03)

An instructional diagram showing the components of an Atrovent HFA aerosol inhaler, labeled with the canister, mouthpiece, dose indicator, and dustcap. The diagram visually breaks down the inhaler parts for user guidance.*

FDA Label Image

Figure 2 (Atrovent 04)

A line graph depicting a pharmacokinetic or pharmacodynamic profile with values ranging from 0 to 200 on the y-axis, shown at intervals of 20, 40, 60, 80, 100, 120, 140, 160, 180, and 200. The x-axis is not labeled in the visible portion. The graph likely shows measurement of concentration or response over time or dose.*

FDA Label Image

Figure 3 (Atrovent 05)

An instructional line drawing showing the proper technique for using a metered-dose inhaler. The image depicts a person placing the inhaler mouthpiece into their mouth and pressing down the canister to release the medication, illustrating the respiratory administration route typically used with aerosol inhalers like Atrovent HFA.*

FDA Label Image

Figure 4 (Atrovent 06)

An illustration showing a person holding and using a metered-dose inhaler device, demonstrating the correct hand placement and inhalation technique for respiratory administration.*

FDA Label Image

Figure 5 (Atrovent 07)

An illustration showing the use of Atrovent HFA aerosol inhaler with two step-by-step panels. The first panel demonstrates how to hold the inhaler near the mouth with a proper grip, and the second panel depicts inhaling the medication through the mouthpiece. The images guide the proper respiratory inhalation technique for Atrovent HFA (ipratropium bromide) metered aerosol.*

FDA Label Image

Figure 6 (Atrovent 08)

An instructional diagram showing proper use of an Atrovent HFA metered-dose inhaler. The image illustrates a hand holding the inhaler with the mouthpiece positioned for inhalation, demonstrating the correct technique for respiratory administration.*

FDA Label Image

Figure 7a (Atrovent 09)

An illustration of a dose counter window from the Atrovent HFA aerosol inhaler. The counter displays numbers 60, 40, and 20, indicating the remaining doses available in the inhaler.*

FDA Label Image

Figure 7b (Atrovent 10)

An illustration depicting a close-up view of the dose counter window on the Atrovent HFA metered aerosol inhaler, showing the current dose count as part of the inhaler device.*

FDA Label Image

Image (Atrovent 10a)

Atrovent HFA 17 mcg/actuation Metered Aerosol Inhaler packaging label. The label shows the proprietary name Atrovent HFA with the active ingredient ipratropium bromide. The product is presented as a respiratory inhalation aerosol by Boehringer Ingelheim Pharmaceuticals, Inc.*

FDA Label Image

Principal Display Panel (17 mcg Carton)

Label for Atrovent HFA inhalation aerosol containing ipratropium bromide HFA, 17 mcg per actuation. The label includes product and dosing details, warnings, storage instructions, and the Boehringer Ingelheim Pharmaceuticals, Inc. logo. The packaging indicates 12.9 grams per 200 metered actuations with a dose indicator, and states the product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.